These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 9226743)

  • 1. 7-Nitroindazole, a nitric oxide synthase inhibitor, has anxiolytic-like properties in exploratory models of anxiety.
    Volke V; Soosaar A; Kõks S; Bourin M; Männistö PT; Vasar E
    Psychopharmacology (Berl); 1997 Jun; 131(4):399-405. PubMed ID: 9226743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anxiolytic-like effects of 7-nitroindazole in the rat plus-maze test.
    Yildiz F; Ulak G; Erden BF; Gacar N
    Pharmacol Biochem Behav; 2000 Feb; 65(2):199-202. PubMed ID: 10672969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antidepressant- and anxiolytic-like effects of selective neuronal NOS inhibitor 1-(2-trifluoromethylphenyl)-imidazole in mice.
    Volke V; Wegener G; Bourin M; Vasar E
    Behav Brain Res; 2003 Mar; 140(1-2):141-7. PubMed ID: 12644287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possible role of nitric oxide in anxiety following transient cerebral ischemia in mice.
    Nakashima MN; Ajiki K; Nakashima K; Takahashi M
    J Pharmacol Sci; 2003 Jan; 91(1):47-52. PubMed ID: 12686730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anxiolytic effects induced by inhibition of the nitric oxide-cGMP pathway in the rat dorsal hippocampus.
    Spolidório PC; Echeverry MB; Iyomasa M; Guimarães FS; Del Bel EA
    Psychopharmacology (Berl); 2007 Dec; 195(2):183-92. PubMed ID: 17661019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitric oxide-mediated anxiolytic-like and antidepressant-like effects in animal models of anxiety and depression.
    Spiacci A; Kanamaru F; Guimarães FS; Oliveira RM
    Pharmacol Biochem Behav; 2008 Jan; 88(3):247-55. PubMed ID: 17915303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of ventral hippocampal nitric oxide/cGMP pathway in anxiety-related behaviors in rats submitted to the elevated T-maze.
    Calixto AV; Duarte FS; Duzzioni M; Nascimento Häckl LP; Faria MS; De Lima TC
    Behav Brain Res; 2010 Feb; 207(1):112-7. PubMed ID: 19800925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The nitric oxide synthase inhibitor 7-nitroindazole displays enhanced anxiolytic efficacy without tolerance in rats following subchronic administration.
    Dunn RW; Reed TA; Copeland PD; Frye CA
    Neuropharmacology; 1998 Jul; 37(7):899-904. PubMed ID: 9776385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of the nitric oxide synthase inhibitor 7-nitroindazole on the behaviour of mice after chronic ethanol administration.
    Pokk P; Sepp E; Vassiljev V; Väli M
    Alcohol Alcohol; 2001; 36(3):193-8. PubMed ID: 11373254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of nitric oxide-dependent pathways in ethanol-induced anxiolytic effects in rats.
    Ferreira VM; Valenzuela CF; Morato GS
    Alcohol Clin Exp Res; 1999 Dec; 23(12):1898-904. PubMed ID: 10630608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The nitric oxide synthesis inhibitor L-NAME produces anxiogenic-like effects in the rat elevated plus-maze test, but not in the social interaction test.
    Vale AL; Green S; Montgomery AM; Shafi S
    J Psychopharmacol; 1998; 12(3):268-72. PubMed ID: 10958253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anxiolytic-like effects induced by nitric oxide synthase inhibitors microinjected into the medial amygdala of rats.
    Forestiero D; Manfrim CM; Guimarães FS; de Oliveira RM
    Psychopharmacology (Berl); 2006 Jan; 184(2):166-72. PubMed ID: 16362401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The differential role of NOS inhibitors on stress-induced anxiety and neuroendocrine alterations in the rat.
    Joung HY; Jung EY; Kim K; Lee MS; Her S; Shim I
    Behav Brain Res; 2012 Dec; 235(2):176-81. PubMed ID: 22884925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of nitric oxide synthase inhibitors on anxiety in unstressed and stressed mice.
    Gilhotra N; Jain H; Dhingra D
    Indian J Exp Biol; 2010 Apr; 48(4):365-72. PubMed ID: 20726334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 7-Nitroindazole, a neuronal nitric oxide synthase inhibitor, impairs passive-avoidance and elevated plus-maze memory performance in rats.
    Yildiz Akar F; Ulak G; Tanyeri P; Erden F; Utkan T; Gacar N
    Pharmacol Biochem Behav; 2007 Oct; 87(4):434-43. PubMed ID: 17602730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Demonstrating the dose- and time-related effects of 7-nitroindazole on picrotoxin-induced convulsions, memory formation, brain nitric oxide synthase activity, and nitric oxide concentration in rats.
    Vanaja P; Ekambaram P
    Pharmacol Biochem Behav; 2004 Jan; 77(1):1-8. PubMed ID: 14724035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Putative anxiety-linked effects of the nitric oxide synthase inhibitor L-NAME in three murine exploratory behavior models.
    Czech DA; Jacobson EB; LeSueur-Reed KT; Kazel MR
    Pharmacol Biochem Behav; 2003 Jul; 75(4):741-8. PubMed ID: 12957214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glial activation is associated with l-DOPA induced dyskinesia and blocked by a nitric oxide synthase inhibitor in a rat model of Parkinson's disease.
    Bortolanza M; Cavalcanti-Kiwiatkoski R; Padovan-Neto FE; da-Silva CA; Mitkovski M; Raisman-Vozari R; Del-Bel E
    Neurobiol Dis; 2015 Jan; 73():377-87. PubMed ID: 25447229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of nitric oxide synthase causes anxiolytic-like behaviour in an elevated plus-maze.
    Volke V; Kõks S; Vasar E; Bourin M; Bradwejn J; Männistö PT
    Neuroreport; 1995 Jul; 6(10):1413-6. PubMed ID: 7488737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The selective inhibitor of neuronal nitric oxide synthase, 7-nitroindazole, reduces the delayed neuronal damage due to forebrain ischemia in rats.
    Nanri K; Montécot C; Springhetti V; Seylaz J; Pinard E
    Stroke; 1998 Jun; 29(6):1248-53; discussion 1253-4. PubMed ID: 9626301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.